Spartan Bioscience, a world leader in DNA diagnostics, and SUEZ’s Water Technologies and Solutions (“SUEZ”), the company’s global business unit with expertise and global capabilities to help solve the world’s toughest water, wastewater and process challenges, have partnered to bring to market the world’s first on-site molecular (qPCR) Legionella test to their customers. Spartan’s test quickly determines the amount of Legionella bacteria in a water source.
Legionella is a common bacterium that can infect the water systems of large buildings. When infected water systems release aerosolized water droplets contaminated with Legionella, building occupants can breathe in the contaminated air and contract Legionnaires’ disease, a pneumonia that is fatal in 1 in 10 people.
The recent partnership between Spartan and SUEZ brings together SUEZ’s leading water treatment service programs, and cutting-edge investments in innovation and R&D for water and process treatment, with the rapid, molecular diagnostic expertise of Spartan, to bring to market the latest innovative Legionella detection techniques.
“We understand how important it is for our customers to minimize the risk of Legionella in their facilities. That’s why we’ve decided to bring Spartan’s on-site, rapid Legionella test to our customers,” said Dr. Andrew Leach, global product manager for Monitoring Solutions at SUEZ’s Water Technologies & Solutions. “We believe this test will help our customers manage their water systems and ultimately help them mitigate Legionella contamination.”
“We are excited to partner with a world leader in water management like SUEZ. Together, we can bring the latest in on-site molecular Legionella detection to a range of customers, allowing them to react quickly and take the action needed to reduce the likelihood of a Legionella outbreak,” said Dr. Paul Lem, Chief Executive Officer and Founder at Spartan Bioscience.
Read Entire Article